跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-FLUTICASONE AQUEOUS NASAL SPRAY 50MCG/SPRAY - HSA Drug Approval Details
Approvals
/
HSA
/
APO-FLUTICASONE AQUEOUS NASAL SPRAY 50MCG/SPRAY
Approved
THERAPEUTIC
APO-FLUTICASONE AQUEOUS NASAL SPRAY 50MCG/SPRAY
APOTEX INC. (RICHMOND HILL)
🇸🇬 Health Sciences Authority
Approval Date
Jul 5, 2011
Approval ID
a26a3220e2441911
Company
APOTEX INC. (RICHMOND HILL)
Type
Therapeutic
Approval Details
Approval Id
a26a3220e2441911
Drug Name
APO-FLUTICASONE AQUEOUS NASAL SPRAY 50MCG/SPRAY
Product Name
APO-FLUTICASONE AQUEOUS NASAL SPRAY 50MCG/SPRAY
Approval Number
SIN13983P
Approval Date
2011-07-05
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
SPRAY, METERED
Route Of Administration
NASAL
Atc Code
R01AD08
Atc Item Name
fluticasone
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
FLUTICASONE PROPIONATE (micronized)
0.05G/100G
FLUTICASONE PROPIONATE (MICRONIZED)
0.05 G/100 G
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 5, 2011
Approval ID
a26a3220e2441911
Type
Therapeutic
Back to HSA Approvals
